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Strengths and limitations of this study.  
A key strength of this study is that it surveyed a large sample of patients with new onset 
rheumatoid arthritis.  
Participants were recruited from multiple NHS Trusts in the UK to identified delays in access 
to care.    
Data on delay timepoints, demographic characteristics and consultation behaviour were 
gathered from multiple sources including patient self-report, healthcare professionals 
assessment and referral letters.  
Limitations include the fact that data were collected at the point of diagnosis and 
information regarding key dates (in particular the onset of symptoms and presentation to 
primary care) were reliant on patient recall.  
An additional limitation was that the interval between first consultation with a 
Rheumatologist and initiation of treatment was not measured.  
 
 
  
Abstract 
Objective: To investigate delays from symptom onset to rheumatology assessment for 
patients with a new onset of rheumatoid arthritis (RA) or unclassified arthritis. 
Methods: Newly presenting adults with either RA or unclassified arthritis were recruited 
from rheumatology clinics. Data on the length of time between symptom onset and first 
seeing a GP (patient delay), between first seeing a GP and being referred to a 
rheumatologist (general practitioner delay) and being seen by a rheumatologist following 
referral (hospital delay) were captured.  
Results: 822 patients participated (563 female, mean age 55 years). The median time 
between symptom onset and seeing a rheumatologist was 27.2 weeks (IQR 14.1–66 weeks); 
only 20% of patients were seen within the first 3 months following symptom onset. The 
median patient delay was 5.4 weeks (IQR 1.4-26.3 weeks). Patients who purchased over the 
counter medications or used ice/heat packs took longer to seek help than those who did 
not. In addition, those with a palindromic or an insidious symptom onset delayed for longer 
than those with a non-palindromic or acute onset.  The median general practitioner delay 
was 6.9 weeks (IQR 2.3–20.3 weeks). Patients made a mean of 4 GP visits before being 
referred. The median hospital delay was 4.7 weeks (IQR 2.9–7.5 weeks).  
Conclusion: This study identified delays at all levels in the pathway towards assessment by a 
Rheumatologist. However, delays in primary care were particularly long. Patient delay was 
driven by the nature of symptom onset. Complex multi-faceted interventions to promote 
rapid help seeking and to facilitate prompt onward referral from primary care should be 
developed. 
 Introduction:  
 
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting approximately 1% of the 
population.1;2 Rheumatoid arthritis is associated with significant morbidity in large part as a 
consequence of extra-articular co-morbidities associated with systemic inflammation. In the 
UK it has been estimated that RA costs the NHS around £560 million per year and that 
additional costs to the economy of sick leave and work-related disability total £1.8 billion per 
year.3 The first three months following the onset of RA symptoms represents an important 
therapeutic window.4 Treatment during this phase improves long-term clinical outcomes, 
increasing the proportion of patients whose disease enters remission, reducing RA related 
joint damage and reducing the eventual need for joint replacement surgery.5-10 Therefore, it 
is vital that patients are seen by Rheumatologists rapidly following the onset of RA symptoms 
to allow the rapid introduction of disease modifying anti-rheumatic drug treatment. However, 
despite increased recognition of the benefits of early treatment there remains considerable 
delay between symptom onset and the initiation of therapy.11-13 Indeed a report by the UK’s 
National Audit Office (NAO) in 2009 estimated that only 10% of patients with RA were treated 
within three months of symptom onset. The NAO’s modelling suggested significant financial 
benefits for the broader economy and quality of life benefits for the individual if the 
proportion of patients treated earlier was increased.3 
 
The patient’s pathway to care can be delayed for a number of reasons, including delays on 
the part of the patient in recognising the significance of the early symptoms of RA.14-16 Recent 
research has linked patients’ perceptions of RA and coping styles to the length of time taken 
to seek help.17 Before seeking medical help from a  physician, patients may seek help from a 
range of services including complementary therapists, pharmacists and telephone and on-line 
services. However, the use of these services at the onset of inflammatory arthritis has not 
been fully explored. Primary healthcare professionals often find the early symptoms of RA 
difficult to distinguish from those of other rheumatic diseases, making timely and appropriate 
referrals to rheumatologists challenging.18;19 There may thus be delays in healthcare 
professionals making a referral to a Rheumatologist and also in assessment at the secondary 
care level, contributing further to the delay in making a diagnosis and commencing 
appropriate therapy.  
 
Several studies conducted across a range of countries have shown long delays between the 
onset of symptoms and a patient’s first consultation with a rheumatologist.20-23 However, 
data related to lengths of time between the onset of inflammatory musculoskeletal 
symptoms and first seeing a GP, between first seeing a GP and being referred to a 
rheumatologist and being seen by a rheumatologist following referral were not available 
across multiple NHS Trusts in multiple regions of the UK at the time of this study. 
 
Aim 
The aim of this study was to investigate the extents of delay in assessment of patients with 
RA and unclassified arthritis. Specifically the study assessed extents of delay at the level of 
the patient in seeking help from the general practitioner, the general practitioner in 
referring to a Rheumatologist and the Rheumatologist in assessing the patient following 
referral. The relationships between extents of delay and clinical and demographic variables 
were explored and data captured relating to sources of information, help and advice utilized 
by patients prior to GP consultation. 
 
Methods 
A questionnaire based survey of consecutively presenting patients with a new onset of RA or 
unclassified inflammatory arthritis was undertaken in England and Scotland. Networks such 
as the Early Rheumatoid Arthritis Network24 and the National Institute for Health Research 
Clinical Research Network25 were used identify Rheumatology centres to participate in this 
study. RJS also promoted the study during abstract presentations at British Society for 
Rheumatology meetings.   
 
Data were collected from Rheumatology departments in 34 NHS Trusts. Rheumatology 
departments were secondary care based, although one rheumatology department 
(Sandwell and West Birmingham Hospitals) operated clinics in both hospital and community 
settings. Eligible patients were recruited on their first or second visit to the rheumatology 
department following a primary care referral (data were not collected on the numbers of 
patients whose data were collected at their first visit or at their second visit). Rheumatogists 
were asked to approach consecutively presenting patients who met the eligibility criteria. 
Eligible patients were newly referred adults (aged ≥ 18 years) with clinically apparent 
synovial swelling of one or more joints who had either a new onset of RA (according to 2010 
ACR / EULAR criteria 26) or unclassified arthritis (UA; defined as a failure to fulfil classification 
criteria for another inflammatory rheumatic disease). Patients with UA were recruited, as in 
many cases patients with UA at initial secondary care assessment progress to RA over 
time.27   
 Data were collected using two questionnaires (available from the corresponding author on 
request). First, following consent, the recruiting healthcare professional, with the patient 
present, completed a questionnaire that captured data on extents of delays between [1] 
symptom onset and seeing a healthcare professional (from herein referred to as ‘patient 
delay’, these data was gathered from the patient’s account by the recruiting healthcare 
professional), [2] seeing a general practitioner and being referred to a rheumatologist (from 
herein referred to as ‘general practitioner e delay’, these data was gathered from the 
patient’s account by the recruiting healthcare professional), and [3] being referred to a 
rheumatologist and seeing a rheumatologist (from herein referred to as ‘hospital delay’, 
these data were gathered from referral letters and hospital notes). Data were also gathered 
on [1] demographic variables including the patient’s age, gender, education, employment 
status and postcode; deprivation ranks were calculated from postcode data using 
Geoconvert 2010 which produced an Index of Multiple Deprivation (IMD) score,28 [2] clinical 
variables including the  mode of symptom onset (palindromic (defined as intermittent 
symptoms) vs. non-palindromic (defined as persistent symptoms)), rapidity of symptom 
onset (acute vs. insidious; an acute onset was typically viewed as an onset of symptoms 
which came on rapidly over 24-48 hours), duration of morning stiffness, swollen and tender 
joint counts, Disease Activity Score 28 (DAS28) and fulfilment of 2010 ACR/EULAR criteria for 
classification of RA26.  
 
In addition, via a separate questionnaire that patients completed by themselves,  patients 
provided data on actions taken in relation to their symptoms prior to seeking help from 
primary care . The variables captured were informed by previous qualitative research, 
including patient interviews and interviews with healthcare professionals. In addition, we 
had input from Patient Research Partners and the questions asked were validated and 
assessed for reliability29.  
 
Patient and Public Involvement 
Patient and public involvement was an important element of this study. Patient 
representatives from Sandwell and West Birmingham Hospitals NHS Trust were involved in 
the study design, advised on the content of patient facing materials including participant 
information sheets and consent forms and the content of questionnaires including 
questions related to actions taken by patients prior to consulting their GPs. Patients were 
members of the Project Management Group reviewing study recruitment and supporting 
the Group in developing approaches to ensure that recruitment proceeded to time and 
target 
 
Analysis  
To ensure that the data met parametric assumptions, the distribution and levels of 
multicollinearity between variables were checked. Data on patient delays, general 
practitioner delays and hospital delays were not normally distributed, therefore, log values 
of these delay data were created to generate normally distributed variables. 
For each of the outcomes patient delay, general practitioner delay and hospital delay a 
general linear model was used with main effects and two-way interactions for the following 
explanatory variables: gender, ethnicity, IMD score, age, education, employment status, 
mode of onset, rapidity of onset, patient reported family history of RA and RA vs. UA. For 
each outcome any two-way interactions which were not significant were removed in a 
backwards stepwise fashion, with the pairings with the highest p values being removed first. 
All main effects were retained, so that the final model for each outcome included all ten 
explanatory variables and any significant two-way interactions (p<0.01). All significant main 
effects and interactions are reported in the Results section. 
Results 
 
1. Participant characteristics  
Data were collected from 856 patients between 2011 and 2014. Patients were withdrawn 
from the study due to incomplete data (21 cases) and ineligibility (13 cases in whom there 
was no clinical synovitis reported at recruitment). Data were thus analysed from 822 
patients of whom 68.5% were female with a mean age of 55 years. Characteristics of 
patients are presented in table 1.  
Table 1: Demographic and disease related characteristics of patients. Data are presented as 
either percentage (number) or median (IQR) as appropriate. Tender joint count is out of 42 
joints (10 PIP, 10 MCP, 2 wrist, 2 elbow, 2 shoulder, 2 hip, 2 knee, 2 ankle, 10 MTP). Swollen 
joint count is out of 40 joints (10 PIP, 10 MCP, 2 wrist, 2 elbow, 2 shoulder, 2 knee, 2 ankle, 
10 MTP). 
Female 68.5% (563) 
Age, years 57 (45-67) 
Diagnosis of RA  73% (603) 
Ethnicity:         Black British  6.0% (49) 
                          South Asian  
                          White British                           
                          Other  
7.7% (63) 
84.9% (698) 
1.5% (12) 
Self-reported family history of RA 34.9% (287) 
Palindromic onset  42.8% (352) 
Acute onset  35.9% (295) 
Duration of morning stiffness, minutes 60 (10-120) 
DAS28 4.88 (3.98 -5.80)  
HAQ  1.13 (0.50-1.73)  
Tender joint count  9 (4-18) 
Swollen joint count  5 (2-10) 
 
 
 
2. Intervals between symptom onset and first rheumatology consultation 
Overall the median time between symptom onset and seeing a rheumatologist was 27.2 
weeks (IQR 14.1 – 66 weeks); only 20% of patients were seen within the first 3 months 
following symptom onset. The median patient delay was 5.4 weeks (IQR 1.4-26.3 weeks). 
The median general practitioner delay was 6.9 weeks (IQR 2.3–20.3 weeks) with patients 
making a mean of 4 GP visits before being referred. The median hospital delay was 4.7 
weeks (IQR 2.9–7.5 weeks).  
 
Palindromic onset is defined as intermittent symptoms, while non-palindromic is defined as persistent 
symptoms. Acute onset defined as symptoms which came on rapidly over 24-48 hours, while insidious 
onset is defined as symptoms which developed slowly over an extended period of time. Patients 
with a palindromic symptom onset had a significantly longer patient delay than those with a 
non-palindromic onset (9.3 weeks (IQR 2-43 weeks) vs 4.3 weeks (IQR 1-17 weeks); p<0.001, 
t-test). Furthermore, those with an acute symptom onset had significantly shorter patient 
delays than those with an insidious symptoms onset (2.4 weeks (IQR 1 - 6.6 weeks) vs 11.1 
weeks (IQR  4-44 weeks; p<0.001, t-test).  
 
Resources used before seeking help from primary care 
Patients reported taking a range of actions in relation to their symptoms before seeking help 
from their GP and in some cases these actions were associated with longer delays in GP 
consultation (see table 2). Most often patients reported purchasing tablets from ‘the 
chemist’, although only a small proportion actually reported speaking to a pharmacist. 
Other actions reported by patients included applying heat or cold packs to joints or buying 
joint supports.  
 
Table 2. Actions taken by patients with inflammatory arthritis before seeking help from their 
GP with comparison made for patient delay between those who did and did not undertake 
this action using independent t-tests; * P value for comparison of those who did and did not 
undertake this action.  
Actions taken before 
seeking help from GP 
 % (number) of 
participants 
undertaking this 
action 
Median (IQR) 
patient delay in 
weeks for those 
undertaking 
this action  
Median (IQR) 
patient delay in 
weeks for those 
not undertaking 
this action  
P value 
Bought tablets from 
the chemist 
51.1% 
(273 out of 534) 
6.9 (2-30.7) 4.7 (1.4-23) 
 
 
p=0.036  
Used an ice or heat 
pack on joint 
47.8% 
(254 out of 531) 
7.6 (2-30.3) 4.9 (2-26.1) p=0.045 
Took baths 47.4% 
(251 out of 529) 
6.3 (2-30.4) 5.6 (2-26.1) p=0.473 
Bought joint supports 
(splints, tubi-grips 
etc) 
37.4% 
(198 out of 529) 
4.4 (2.1-18.6)  5.1 (2-26.9) p=0.362 
Used alternative 
therapies 
25.2% 
(134 out of 531) 
8.3 (2-42.1) 5.3 (2-26.3) p=0.020 
Bought products 
from a health shop 
19.0% 
(101 out of 532) 
5.9 (2-36.3)  5.9 (2-26) p=0.182 
Modified diet  14.4% 
(76 out of 529) 
6 (2.1-35.3) 6.1(2-26.3) p= 0.183 
Used prayer or 
sought spiritual 
guidance 
8.4% 
(45 out of 534) 
4.4 (2.1-18.6) 6.3 (2-26.9) p=0.941 
Spoke to a 
pharmacist 
7.9% 
(41 out of 521) 
5.9 (2-38.1) 5.9  (2-26.3) p=0.544 
 
 
Thirty-seven percent of patients reported looking on the internet (for example visiting the 
NHS direct website, BUPA website, Arthritis Research UK website and searching for 
information using search engines such as Google). Patients also reported seeking support via 
a telephone helpline; 5.7% described calling the NHS direct helpline or another telephone 
health advice service. 3.7% sought help in the workplace (e.g. from an occupational nurse), 
2% of patients went directly to the Accident and Emergency Department and 1% attended 
an NHS walk-in centre.  
 
Multivariate analysis: Patient delay 
The interaction model showed main effects for mode of onset (palindromic vs. non-
palindromic; F=26.65, P<0.01) and rapidity of onset (acute vs. insidious; F= 65.36, P<0.01). 
An interaction was found between palindromic onset and gender (F=45.658, P<0.01); men 
with a palindromic onset waited significantly longer before seeking help. 
 
  
Multivariate analysis: General practitioner delay  
A main effect was found for ethnicity (F=6.26, P<0.01). Significant differences in general 
practitioner delay were found between White British and South Asian patients (6.2 weeks 
(IQR 2-18.6) vs 22 weeks (IQR 6.5-39.8); P<0.001) and between White British and Black 
British patients (6.2 weeks (IQR 2-18.6) vs 11.1 weeks (IQR 4.3-21.7); P<0.001). No 
significant difference was found between South Asian and Black British patients (P=1.000).  
A main effect was also found for family history (F=5.89, P<0.01); the median general 
practitioner delay for those with a self-reported family history of RA was 9 weeks (IQR 2.4-
25.7), while general practitioner delay for those with no family history was 6.3 weeks (IQR 
2.3-19). Interactions at a statistically significant level (<0.01) were not found.  
 
Multivariate analysis: Hospital delay  
 
The original model included main effects and two-way interactions for the following 
explanatory variables:  gender, ethnicity, IMD score, age, education, employment status, 
mode of onset, rapidity of onset, family onset and RA vs. UA. None of the main effects or 
interactions (when removed backwards) were significant in predicting the delay between 
referral and being seen in secondary care.   
 
  
Discussion  
 
International guidelines recommend that the treatment of RA should begin as soon as 
possible after the onset of symptoms, ideally aiming to capture patients within the first 3 
months following symptom onset. However, this large UK study of delays in access to care for 
RA patients found that the median patient delay in seeking help at the onset of symptoms 
was 5.4 weeks, while the median delay between seeing a healthcare professional and being 
referred was 6.9 weeks. Our study highlights that only 20% of patients were seen within the 
first 3 months of symptom onset. This appears to be lower than the rate reported in other 
European countries for example a recent study in Austria reported at 38% of patients were 
seen within the first 3 months30. The present study also found an average delay of  4.7 weeks 
from referral until the patient was seen by a rheumatologist, similar to figures reported in the 
NAO report3. Unlike our previous study conducted at a  single centre in the UK where patient 
delay accounted for the largest element of delay,13 we found that GP delay was the largest 
contributor to overall delay; patient delay was less than we had previously reported in our 
single centre study. 
 
This research highlights that delays in primary care are long, and a major contributor to 
overall delays between symptom onset and the first rheumatology visit. General 
practitioners are faced with a number of barriers to identifying patients with newly 
presenting RA including the often non-specific nature of symptoms at the earliest stages of 
RA.18 Research is underway to define symptom complexes most predictive of RA 
development in patients with newly presenting musculoskeletal symptoms. For example, a 
questionnaire has been developed and validated to capture such symptoms in patients 
presenting with joint symptoms which by history are suggestive of an underlying 
inflammatory cause31 and data are currently being collected from such patients in secondary 
care based longitudinal observational cohort studies to identify symptoms that may predict 
RA development. Furthermore an assessment of primary care databases has identified a 
range of symptoms including hand related joint symptoms, morning stiffness and carpal 
tunnel syndrome type symptoms as being ones with which patients frequently present to 
the GP prior to the point at which the GP refers the patient to a Rheumatologist or records a  
diagnosis of RA 32 It is likely that a combination of education, and evidence based referral 
algorithms, will be needed to ensure that suspected cases are referred early. For example, 
in Fife, Scotland GPs did not have access to rheumatoid factor testing during the course of 
our study, and used guidelines with pictorial representations to help identify early synovitis 
(personal communication Dr Helen Harris). Fife was a participating centre in this study, and 
was found to have the lowest GP referral time of all centres surveyed. Furthermore, 
facilitating access to secondary care, for example through the establishment of rapid 
assessment clinics whose main aim is to identify whether the patient does or does not have 
synovitis have been shown to significantly reduce delays in the assessment of patients.33 A 
limitation of our research is that the study was not able to assess regional differences across 
NHS Trusts. A study comparing delays and referral patterns between hospitals with local 
policies and practices which may influence the time between onset and first consultation 
would be useful and an international study would be particularly helpful. In addition, this 
study did not examine the distances between patients' homes and their local GP surgeries, 
and hospital and so we were unable to assess whether physical distance between the 
patient’s home and the GP surgery or hospital influenced delay. 
 
A number of factors were found to influence GP delay including ethnicity. Studies in the field 
of oncology have also found that people from ethnic minority backgrounds face longer GP 
delays.34;35 In the context of RA it is possible that the early symptomatology of patients from 
ethnic minority backgrounds is different from, and less typical of RA than that of, patients of 
white British background, thus making recognition more challenging for GPs. Data certainly 
exist that the clinical phenotype of established RA differs in patients of South Asian origin 
compared with patients of White British origin,36 though data relating the clinical 
presentations of RA in these groups are lacking. Furthermore, it is unclear why a self-
reported family history of RA would be associated with longer delays although it is 
important to recognise that GPs may not have elicited this information from the patient.37  
Qualitative approaches may be helpful to address some of these issues in the future.  
  
Previous qualitative studies and a meta-synthesis have identified barriers to help seeking at 
the onset of RA.37-43 The present study identifies that before seeking formal medical 
attention, people experiencing the early symptoms of RA seek information and help from a 
number of alternative sources and often self-medicate. We identified that buying tablets 
from a pharmacy, and using heat or ice on joints was significantly associated with longer 
patient delays. This finding highlights that some self-management behaviours, particularly 
those linked to accessing pharmacy services can negatively impact on the time it takes to 
seek help; this needs further exploration.  Factors previously suggested to be associated 
with delays in GP consultation included an insidious onset of mild symptoms and a lack of 
knowledge about RA, personal susceptibility to RA and the availability of treatments to slow 
disease progression. In our national sample 64.1% of people describe an insidious onset of 
RA, and 42.8% describe a palindromic onset of RA. Therefore, majority large proportion of 
patients surveyed experienced a slow and / or intermittent onset of their inflammatory joint 
symptoms. Our quantitative data are thus consistent with results from qualitative studies, 
demonstrating that the mode and rapidity of onset of symptoms is significantly associated 
with patient delays.  
This study has a number of limitations. Firstly, the interval between first consultation with a 
Rheumatologist and initiation of disease modifying anti-rheumatic drug (DMARD) treatment 
was not measured. Any additional delay in commencing DMARD treatment will negatively 
impact the patient and variables associated with delays at this level should be assessed in 
future studies.   Secondly, during the course of this study a number of guidelines related to 
RA management were published which may have influenced practice, and patterns of 
referral. We were not able to explore the relationships between the availability / local 
adoption of guidelines and  delays in the assessment of patients. Future investigation should 
assess the impact of policy changes on patterns of help-seeking, referral and assessment. 
Thirdly, the rheumatology centres participating in this study were self-selecting, therefore, 
there may be biases in the characteristics of the rheumatology centres which participated in 
this study. For example, the participating rheumatology units may have had a particular 
interest in early arthritis. Only a study which recruited consecutive patients from all 
rheumatology units across the UK would be able to provide a truly national picture. 
Fourthly, whilst we were able to document the length of delay at a primary care level there 
were important variables which may have influenced this delay which we did not record and 
so were unable to explore.  For example it would have been helpful have access to results 
tests performed in primary care to assess whether levels of inflammatory markers or RA 
related autoantibodies  measured in primary care influenced the rapidity of referral from 
primary care. Indeed a recent quantitative survey of GPs’ anticipated actions in primary care 
when dealing with patients with suspected RA suggest that results of these tests may 
influence GP behaviours44. Future research should address this. Similarly, a number of 
secondary care related variables may have influenced the extent of secondary care delay 
including the number of rheumatologists at each Trust, whether a dedicated early arthritis 
clinic was in place and approaches taken to the triage of referrals. Data relating to these 
variables were not collected though future work addressing issues of delay should address 
these important issues. Fifthly, data relating to the dates of onset of symptoms and initial 
GP consultation were gathered from patients’ histories, and therefore relied on patient 
recollection with a possible associated error. However, a previous study addressing delays in 
the assessment of patients with RA, compared patient accounts of their journeys to first 
rheumatology consultation against medical records and highlighted the accuracy of patient 
recollection in relation to dates found to be documented in primary care records45. This, to 
some extent, validates our approach of using patient memory to define the dates of 
symptom onset and initial GP presentation.   An alternative approach would be a 
longitudinal observational study in the general population to track the development of 
symptoms and the relationship between that and GP consultation, GP referral and 
secondary care assessment. A challenge with this approach is the low incidence of RA and 
thus the requirement for a very large sample size. One could potentially enrich the 
population for RA risk by, for example, following individuals who are at increased risk of RA 
(e.g. the first degree relatives of patients with RA). However, one of the challenges with this 
strategy is that simply being involved in such a study may influence subsequent patient and 
GP behaviour.  
 
Whilst delays in primary care are the largest contributor to overall delay, patient delay and 
hospital delay represent important components. This study found that the nature of 
symptoms onset influenced how quickly patients with RA sought help, suggesting that those 
with an acute onset of persistent symptoms seek help faster than those with insidious and 
palindromic onsets. Interventions to encourage rapid help seeking should consider 
highlighting the frequently insidious onset of RA to members of the public stressing that 
help should be sought even when symptoms are mild. However, even those with a  rapid 
onset of persistent symptoms often delayed for prolonged periods before seeking help. We 
have previously shown that members of the public view musculoskeletal symptoms, even 
those with clear inflammatory features, as less worrisome and less requiring rapid 
assessment as compared with symptoms of other common diseases such as ischaemic type 
chest pain or bowel disturbance with associated rectal blood loss46. Enhanced public 
education to highlight the significance of inflammatory type musculoskeletal symptoms is 
thus likely to be needed. Interventions at multiple levels, including at the levels of the 
public, the services which members of the public consult after the onset of symptoms (e.g. 
pharmacies), primary care and secondary care will be needed to reduce overall delays in 
access to appropriate specialists.  
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